Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

New drugs will bring revolution in hepatitis C treatment

News
18 October 2013
The search for a cure

Bristol-Myers Squibb launches initiative to support search for cure in chronic viral diseases

Editor's pick
Bristol-Myers Squibb press release
17 October 2013
HIV prevention policy

Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy

News
16 October 2013
Hepatitis C treatment

The uncomfortable truth: Hepatitis C in England

Editor's pick
Hepatitis C Trust
15 October 2013
Hepatitis & HIV

Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013

Editor's pick
British HIV Association
15 October 2013
Hepatitis C treatment

Hepatitis C Trust says strategy urgent as related liver disease on the rise

Editor's pick
The Guardian
14 October 2013
New & experimental hepatitis C treatment

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients

Editor's pick
Healio Hepatology
14 October 2013
New & experimental hepatitis C treatment

Enter the Nonspecialist: Will Evolving Hepatitis C Therapies Reduce the Need for Specialized Care?

Editor's pick
Clinical Care Options (requires registration)
14 October 2013
New & experimental hepatitis C treatment

Predicting response to acute hepatitis C treatment in HIV/HCV co-infected people

News
14 October 2013
Hepatitis C symptoms & diagnosis

Lack of HCV Genetic Diversity Tied to Higher Liver Disease Risk in Women With HIV

Editor's pick
NATAP
12 October 2013
New & experimental hepatitis C treatment

Daclatasvir works well against hepatitis C either with interferon or in all-oral regimen

News
10 October 2013
New & experimental hepatitis C treatment

Idenix Shares Fall as J&J Buys Rival Hepatitis C Therapy

Editor's pick
Bloomberg
8 October 2013
New & experimental hepatitis C treatment

Investigational interferon-free regimen demonstrates undetectable hepatitis C virus in all patients reaching end of treatment in ongoing Phase II trial

Editor's pick
Boehringer-Ingelheim press release
8 October 2013
New & experimental hepatitis C treatment

Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

Editor's pick
Janssen press release
8 October 2013
Hepatitis C treatment

Health Department Announces Plan to Combat Hepatitis C

Editor's pick
New York City Department of Health and Mental Hygiene (press release)
8 October 2013
Hepatitis B

Vaccination campaign doubles HBV mutations

Editor's pick
Eurekalert Medicine & Health
8 October 2013
Treatment outcomes & life expectancy

Liver fibrosis linked to immune activation in HIV/HCV co-infected women

News
7 October 2013
Hepatitis C transmission & prevention

Hepatitis C education crucial to cut high infection rate in Middle East and North Africa

Editor's pick
The National
7 October 2013
Cancer

Liver cancer often diagnosed late with poor survival in people with HIV

News
4 October 2013
Hepatitis C transmission & prevention

Is HCV infection spreading among HIV-positive gay men in Japan?

News
4 October 2013
Hepatitis C symptoms & diagnosis

Canada should screen all baby boomers for hepatitis C, experts argue

Editor's pick
The Globe and Mail
1 October 2013
Hepatitis B

FDA Warns of Hepatitis B Reactivation Risk with Immune-suppressing Cancer Drugs

Editor's pick
HIVandhepatitis.com
30 September 2013
New & experimental hepatitis C treatment

Achillion's Hepatitis C Drug Still on Hold by U.S. FDA

Editor's pick
Bloomberg
30 September 2013
Hepatitis C treatment

New publication: "Management of tuberculosis and HIV coinfection"

Editor's pick
WHO Europe
27 September 2013